Whitebox Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Whitebox Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-95,193	Closed	-$3.16M	–	398
2014 Q4	$3.16M	Buy	95,193 +3,174	+3%	+$103K	0.13%	134
2014 Q3	$2.7M	Buy	92,019 +70,965	+337%	+$2.36M	0.1%	173
2014 Q2	$818K	Buy	+21,054	New	+$854K	0.03%	321
2014 Q1	–	Sell	-114,768	Closed	-$3.77M	–	433
2013 Q4	$3.77M	Buy	114,768 +45,594	+66%	+$1.49M	0.17%	95
2013 Q3	$1.87M	Buy	+69,174	New	+$1.95M	0.1%	143

Other funds holding LGND

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Whitebox Advisors's LGND Position: Q1 2015 in Review

Whitebox Advisors sold out of Ligand Pharmaceuticals (LGND) in Q1 2015, closing a stake of 95,193 shares — an estimated $3.16M sold.

Whitebox Advisors first reported a position in LGND in Q3 2013 and held it in 5 quarters. The position peaked at $3.77M in Q4 2013. 187 funds tracked by Wall St. Rank hold LGND as of Q1 2015.

Whitebox Advisors reported no remaining Ligand Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Whitebox Advisors sold 95,193 Ligand Pharmaceuticals shares in Q1 2015, an estimated $3.16M.
Whitebox Advisors first reported a position in Ligand Pharmaceuticals in Q3 2013 and held it in 5 quarters.
Whitebox Advisors's Ligand Pharmaceuticals position peaked at $3.77M in Q4 2013.
187 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2015.

Based on Whitebox Advisors's 13F filing for Q1 2015, filed 12 May 2015.